PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ)

CUSIP: 71426V306

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM NEW
Total 13F shares
2,019,656
Share change
+87,326
Total reported value
$4,845,400
Put/Call ratio
104%
Price per share
$2.40
Number of holders
18
Value change
+$182,047
Number of buys
6
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 71426V306?
CUSIP 71426V306 identifies PTXTQ - PERNIX THERAPEUTICS HLDGS IN - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) as of Q4 2017

As of 31 Dec 2017, PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,019,656 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, Aisling Capital LLC, BlackRock Inc., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, JACOBS LEVY EQUITY MANAGEMENT, INC, Cetera Investment Advisers, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and GOLDMAN SACHS GROUP INC. This page lists 18 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.